Infection Clinical Trial
Official title:
Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection in Senegal
Despite economic growth in developing countries, Sub-Saharan Africa still faces food
insecurity malnutrition and infections. Micronutrient deficiency and infectious diseases
still remain a public health problem and have a negative impact on health and the economy.
They are both directly and indirectly responsible for children morbidity and mortality. Due
to high level of children mortality (139‰) Vitamin A Supplementation (VAS) program was
implemented in Senegal since 1999. A national representative study undertook in 2010 to have
biological data on vitamin status and infections, showed that 24.4% of children aged 1-5 y
were Vitamin A Deficiency (VAD) and 50.2% were infected. To address VAD issue, large scale
oil fortification was launched by government and private industries also fortified bouillon
cubes. Furthermore, home fortification is being initiated without evaluation of VAD control
strategies existing in the country.
In order to assess the impact of national VAD control strategies in Senegalese children, this
study was designed to measure in subsample of rural children aged 3-5 y, the current vitamin
A total body stores in relation to their infectious status.
Specifics objectives are:
Assess total body vitamin A stores and hepatic reserves before and after vitamin A
supplementation in children aged 3-5 y by deuterated-retinol dilution technique Measure
plasma retinol, ferritin and zinc concentrations in children Measure plasma C-reactive
protein and alpha 1 glycoprotein concentrations and malaria parasitemia Identify health,
socioeconomic and food determinants that can influence children micronutrient status
Study design is longitudinal with repeated measures and will be implemented in rural area.
Five months after the passage of Vitamin A Supplementation (VAS) campaign, fifty children
(n=50) aged 3-5y will be enrolled in the study (randomized sampling) plus 10% for drop out.
The protocol will be explained to the mother and written consent will be obtained from her.
Dietary intake information will be collected using 24 hour recall questionnaire, food
frequency questionnaire and infections frequency questionnaire will be submitted to the
mother at d-7. Anthropometric measurements (weight and height) of children will be recorded
also at d-7.
Subjects will receive doses of labeled vitamin A:
6µmol of D4-Vitamin A, and 6 µmol of D8-Vitamin A per children at d0 and d44 respectively.
Blood sampling will be done 3 times during the study: at Baseline (d-7) and 2 weeks after
each dose of labeled vitamin A (d14 and d58). The blood will be drawn from children and
immediately wrapped on aluminum foil and placed in a cooler while in the field. The blood
samples will be transported to the lab and treated under dim light (centrifugate and
separation in cryogenic vials). C - reactive protein (CRP) and alpha-1 acid glycoprotein
(AGP) will be measured by Elisa method. Serum retinol measurement will be done by HPLC after
ethanol hexane extraction with 200 µl of serum and vitamin A total body stores by GC-MS.
Others micronutrient determination will be done as Iron (ferritin by Enzyme Linked
Fluorescent Assay (ELFA)) and Zn (Atomic Absorption Spectrophotometer by flame).
Anemia will be assessed by measuring hemoglobin (Hb) in whole blood using a HemoCue system
(Hb-301) and malaria parasitemia will be measured using Rapid Diagnostic tests (RDT)
Statistical analyses will be carried out with STATA / SE (Special Edition, Stata Corporation,
Texas, USA). The results will be expressed as mean ± standard deviation and percentages. The
variables with non Gaussian distributions will undergo a logarithmic transformation and will
be expressed in geometric mean ± standard deviation.
The analysis of variance (ANOVA) associated with a posteriori test (Bonferroni) will be used
for repeated measures and Student's t test will be used for comparison of means. The Chi²
test will be used for percentages comparison.
The relationship between quantitative variables will be assessed with the Pearson correlation
coefficient. Multiple and logistic regression will be performed to identify the
socio-economic, health and dietary determinants of vitamin A status, evaluate their
contributions and their influence on the risk of vitamin A deficiency. For all these
statistical analysis, a significance level of 0.05 will be applied.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |